Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
Hupperets
P S
PS
Tjan-Heijnen
V C
VC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000517:prevention & control; D043823:Taxoids / Q000627:therapeutic use
D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D003520:Cyclophosphamide